High Potent Manufacturing

  • High Potent Manufacturing 1
  • High Potent Manufacturing 2
Product Description

Manufacturing site dedicated to OSD forms incorporating high potent APIs EOB 4/5 (OEL up to < 0.03 µg/m3).
Bluepharma has dedicated R&D centers and scale-up facilities that are well equipped in the formulation and pilot-scale equipment as well as analytics (covering a wide range of techniques). Our most recent manufacturing site is fully dedicated to solid dosage forms incorporating high potent APIs (OEL up to < 0.03 µg/m3). 

Our project managers and tech transfer team offer the required mindset to the partner’s needs, namely in terms of efficiency, compliance and competitiveness.

Due to our extensive international track record (successfully inspected by FDA, EMA, ANVISA, among others), we collaborate globally with major pharmaceutical companies, distributing medicines worldwide, namely in the United States, Europe, the Middle East and LATAM.

We can offer a one-stop-shop service, tailored to our client's needs and expectations.
Schedule a meeting with Bluepharma to know more about our services,
 

Read more Show less

Bluepharma Industria Farmaceutica S.A.

  • PT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Portugal
More specifications Fewer specifications
Sales Markets
Show more Show less

Bluepharma Industria Farmaceutica S.A.

  • PT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Bluepharma Industria Farmaceutica S.A. (4)

  • Clinical Manufacturing

    Product Clinical Manufacturing

    .Integrated drug development service (CRO/CDMO) including clinical manufacturing and management.
    The range of activities offered by Bluepharma includes:
    - Clinical material cGMP manufacturing
    - Clinical supply management
    - clinical material
    - placebo
    - ...
  • Complex Sterile Formulations Contract Development

    Product Complex Sterile Formulations Contract Development

    +25 Years of accumulated experience in Lipid and polymer-based formulations.
    Regarding Complex Injectables, Bluepharma's focus is on Lipid-based, polymer-based, and Long-acting injectable (LAI) formulations. Bluepharma allies the scientific expertise with the technical capability to ensure the success...
  • Drug Delivery Platforms

    Product Drug Delivery Platforms

    Modified release, hot-melt extrusion, ODT, oral thin films, oral sprays, and polymer-based solutions,

    Our range of technologies covers solid dosage forms (IR and ER), polymer-based solutions, solid dispersions (hot-melt extrusion), oral sprays, oral thin films, and complex injectables ...
  • Pharmaceutical development (CDMO) & Exclusive portfolio

    Product Pharmaceutical development (CDMO) & Exclusive portfolio

    From research, pre-formulation, and formulation development, up to commercial manufacturing  (including HPAPI).
    Bluepharma offers an integrated drug development service (CDMO) from research, pre-formulation, and formulation development, up to commercial manufacturing ...

Bluepharma Industria Farmaceutica S.A. resources (5)

  • Bluepharma´s Presentation

    Video Bluepharma´s Presentation

    Bluepharma is a Portuguese Group with more 20 years, more than 700 employees and 20 innovative companies that cover all stages of the pharmaceutical industry value chain of the drug, from R&D to the market, imposing itself for the excellence of its production unit, the quality and training of its employees and the experience and dynamism of its management team.
    2022-08-19
  • Differentiated Portfolio

    Brochure Differentiated Portfolio

    Unlock a world of complex generics & value-added products in our differentiated portfolio, serving the global market. Explore excellence today!
  • Platforms for Value Added Medicines (VAM)

    Brochure Platforms for Value Added Medicines (VAM)

    Discover our innovative portfolio & collaborative approach to bring your ideas to life. Explore value-added solutions with us today!
  • Diversified and exclusive portfolio

    Brochure Diversified and exclusive portfolio

    Development and Licensing Opportunities.

    Due to our extensive international track record (successfully inspected by FDA, EMA, ANVISA, among others), we collaborate globally with major pharmaceutical companies,  by licensing out our own technology or distributing our own brand worldwide, namely in the United States, Europe, Middle East, APAC, China and LATAM. 
  • “Reflections in Future”, Bluepharma´s 20 years celebration photographic exhibition.

    Video “Reflections in Future”, Bluepharma´s 20 years celebration photographic exhibition.

    www.bluepharma20anos.pt

    Bluepharma turns 20 years in 2021! 20 years that have passed like a flash.

    To honor all employees who have been part of these two decades, Bluepharma has prepared a photographic exhibition entitled “Reflections in Future”, with photos by Pedro Medeiros.

    “Reflections in Future” is an exhibition with 20 photographs that celebrates the 20th Anniversary of Bluepharma, the Portuguese pharmaceutical company that was born in Coimbra and that, step by step, went from a unit with 58 workers to a group of 20 companies, with 700 employees, including 260 researchers.

    With all the authenticity achieved by the telephoto lens, centered on People, Investment, Research and Quality, we present you the challenge posed in each procedure.

    This exhibition can also be seen as a dynamic and didactic display of the complexity of the pharmaceutical industry's value chain.

    From Research & Development to kno...
    2021-03-04